CAP | CAP + PPE | p value | |||
---|---|---|---|---|---|
Characterisics | n a | % | n | % | |
Overall | 24 | 46 | 28 | 54 | |
Gender | |||||
Male | 18 | 75 | 12 | 43 | 0.025 |
Age | |||||
3–23 months | 6 | 25 | 6 | 21 | 1 |
24–59 months | 12 | 50 | 10 | 36 | 0.4 |
5–14 years | 6 | 25 | 12 | 43 | 0.24 |
Vaccinated with | |||||
PCV-7b | 8 | 33 | 15 | 54 | 0.17 |
Hib | 1 | 88 | 24 | 86 | 1 |
Therapy before admission | |||||
NSAIDc | 16 | 67 | 22 | 79 | 0.4 |
Antibiotic | 7 | 29 | 15 | 54 | 0.09 |
Median duration of hospitalisation (days) | 3 | 15 | < 0.01 | ||
Number of patients treated by oxygen therapy | 4 | 17 | 22 | 79 | < 0.001 |
Median duration of symptoms before admission (days) | 3 | 7 | 0.0065 |